CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 36 enrolled
Drug / intervention
ACUVUE OASYS® 1-DAY with HydraLuxe™ TECHNOLOGY (AO1D)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06333613
NCT06333613N/ACompleted
CompareCT.gov

Evaluation of Acuvue Oasys 1-Day Contact Lenses in New Wearers

Johnson & Johnson Vision Care, Inc.·interventional·Posted Mar 27, 2024·Updated Jun 3, 2025

In Brief

A clinical study evaluating ACUVUE OASYS® 1-DAY with HydraLuxe™ TECHNOLOGY (AO1D) for Visual Acuity. Completed, enrolled 36 participants across 5 sites.

Detailed Summary

This is a multi-site, bilateral, dispensing, non-randomized, uncontrolled, unmasked, single arm study to evaluate visual acuity in neophytes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedMar 27, 2024
Enrollment StartMar 26, 2024
Primary CompletionMay 22, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.3 years ago

Interventions

ACUVUE OASYS® 1-DAY with HydraLuxe™ TECHNOLOGY (AO1D)device

Test Lens